Mehrdad SalekShahabi

Mehrdad SalekShahabi

Auto-generated profile, based on publicly available information

Mehrdad SalekShahabi

Department of Medicine, TaMS.C. Islamic Azad University Tabriz Iran

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2026 in Experimental Physiology
Verified
Journal Article
Open access
AGAmir Arsalan Ghahari
Amir Arsalan Ghahari
MNMehrdad Nourizadeh
Mehrdad Nourizadeh
MSMehrdad SalekShahabi
Mehrdad SalekShahabi
SDShaghayegh Davari
Shaghayegh Davari
SMSaeid Mohammadzadeh Mounesyar
Saeid Mohammadzadeh Mounesyar
The global rise in mental health conditions has prompted interest in interventions that act beyond conventional psychopharmacology. Psychobiotics, broadly understood as live microorganisms or microbe‐derived products that interact with the microbiota–gut–brain axis, have been suggested to exert neuroactive effects through neural, immune, endocrine and metabolic routes. This narrative review synthesizes recent preclinical, mechanistic and early clinical observations. Experimental studies show that selected strains can modulate cytokine signalling, influence stress‐responsive systems such as the hypothalamic–pituitary–adrenal axis, and support synaptic plasticity via factors such as brain‐derived neurotrophic factor. A limited number of human trials using well‐characterized Lactobacillus and Bifidobacterium strains have reported improvements in affective and stress‐related outcomes, but these effects are generally small to moderate, more apparent in adjunctive than stand‐alone use, and dependent on strain, dose, population and intervention length (typically 4–12 weeks). Evidence on neurodevelopmental conditions (e.g., autism spectrum disorder, attention‐deficit/hyperactivity disorder) remains preliminary, based on small and heterogeneous samples. Across studies, key constraints include methodological heterogeneity, incomplete strain‐level reporting, and gaps in mechanistic resolution that make it difficult to link microbial shifts to psychiatric benefit. Emerging microbiome‐ and metabolomics‐informed approaches may help identify likely responders and improve translational precision, but they are not yet ready for routine clinical application. Overall, psychobiotics should currently be viewed as a promising adjunct within integrative mental health care, warranting larger, standardized trials with clearly defined strains, doses and mechanistic endpoints.

28 February 2026 in Journal of Renal Injury Prevention
Verified
Journal Article
Closed access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
AMA. Mokhtariardekani
A. Mokhtariardekani
HSH. Sanadgol
H. Sanadgol
SHS. Hosseinian
S. Hosseinian
MSM. SalekShahabi
M. SalekShahabi
ZMZ. Hamidi Madani
Z. Hamidi Madani
Insulin resistance in polycystic ovary syndrome (PCOS) contributes to renal dysfunction through multiple interconnected mechanisms. In PCOS, insulin resistance leads to compensatory hyperinsulinemia, which exacerbates metabolic disturbances including hyperandrogenism and systemic inflammation. These factors collectively promote renal injury. Meanwhile, insulin resistance in PCOS promotes hypertension and endothelial dysfunction, which impair renal microcirculation. Hyperinsulinemia increases sodium retention and activates the renin-angiotensin-aldosterone system (RAAS), further elevating blood pressure and causing glomerular hyperfiltration and damage. Insulin resistance also contributes to dyslipidemia and oxidative stress, accelerating atherosclerosis and renal vascular injury. Moreover, insulin resistance worsens hyperuricemia by reducing renal uric acid excretion, which is a direct nephrotoxic factor. Persistent hyperuricemia leads to inflammation and fibrosis within the kidneys, potentially progressing to chronic kidney disease (CKD). In addition, systemic low-grade inflammation and oxidative stress driven by insulin resistance and PCOS-related hyperandrogenism also induce renal tissue injury through inflammatory cytokines and apoptotic pathways, contributing to impairment in renal function.